ARTICLE | Company News
Philogen, Pfizer deal
January 7, 2013 8:00 AM UTC
Philogen granted Pfizer exclusive, worldwide rights to develop and commercialize Dekavil, an immunocytokine consisting of a vascular targeting antibody fused to the anti-inflammatory cytokine IL-10. ...